Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.

The bronchopulmonary and plasma pharmacokinetics of clarithromycin (CLA; 500 mg given twice daily for nine doses) or azithromycin (AZ; 500 mg for the first dose and then 250 mg once daily for four doses) were assessed in 41 healthy nonsmokers. Bronchoalveolar lavage was performed at 4, 8, 12, or 24...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Patel, K B, Xuan, D, Tessier, P R, Russomanno, J H, Quintiliani, R, Nightingale, C H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163537/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8891147/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.10.2375
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!